Search clinical trials for: Bivalirudin

Total 75 results

Nanjing First Hospital, Nanjing Medical University

Completed

Safety and Efficacy of Prolonged Use of Bivalirudin 4 Hours After ePCI (COBER Study)

Coronary Heart Disease

China
The Medicines Company

Completed

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Thrombosis | Thrombocytopenia | Cardiac Disease | Coronary Artery Bypass Surgery

United States
The Medicines Company

Withdrawn

Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) Patients

Heparin-Induced Thrombocytopenia | Heparin-induced Thrombocytopenia and Thrombosis Syndrome

United States
The Medicines Company

Completed

Bivalirudin as a Procedural Anticoagulant in Pediatrics

Cardiology
The Medicines Company

Completed

Study Of Angiomax In Infants Under Six Months With Thrombosis

Thrombosis

United States
The Medicines Company

Completed

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB (HIT/TS)

Cardiovascular Disease | Coronary Artery Bypass Surgery

United States
Italian Society of Invasive Cardiology
Eustrategy

Unknown

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)

STEMI | Acute Coronary Syndromes | NSTEMI

Italy
The Medicines Company

Completed

Bivalirudin in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary PCI

Myocardial Infarction

United States
Hamad Medical Corporation

Unknown

Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial

Anticoagulation in COVID-19 ARDS

Qatar
The Medicines Company

Completed

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Thrombosis | Heparin-Induced Thrombocytopenia

United States
Chinese PLA General Hospital

Unknown

Bivalirudin in Stable Ischemic Heart Disease Patients Undergoing PCI

Coronary Disease

China
The Medicines Company

Completed

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS)

Myocardial Infarction | Acute Disease | Unstable Angina

United States
Nycomed

Withdrawn

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

Coronary Disease
Changhai Hospital
Wuhan University; Qilu Hospital of Shandong University; The First Affiliated... and other collaborators

Unknown

Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms (BUILD)

Subarachnoid Hemorrhage, Aneurysmal
LifeBridge Health

Unknown

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

Coronary Artery Disease

United States
Careggi Hospital

Completed

Antithrombotic Regimens and Outcome (ARNO)

Coronary Artery Disease

Italy
Azienda Ospedaliera San Camillo Forlanini

Unknown

FIT (Fast Infarction Treatment): Complete Revascularization During Primary Percutaneous Coronary Intervention (PCI) Can be Achieved Safely With an Improved Clinical Outcome During the Indexed Hospitalization. (FIT)

Myocardial Infarction | Ischemia | Necrosis | Heart Failure | Stents

Italy
Juan J Badimon
AstraZeneca

Completed

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Acute Coronary Syndrome

United States
Peking University First Hospital

Recruiting

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation. (PCI)

Coronary Microvascular Dysfunction

China
Uppsala University
Lund University

Completed

Bivalirudin vs Heparin in NSTEMI and STEMI in Patients on Modern Antiplatelet Therapy in SWEDEHEART (VALIDATE)

ST-segment Elevation Myocardial Infarction | Non ST-segment Elevation Myocardial Infarction

Sweden
Xijing Hospital

Unknown

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty

ST-elevation Myocardial Infarction

China
Johns Hopkins University

Withdrawn

Bivalirudin vs Heparin in ECMO Patients

Extracorporeal Membrane Oxygenation Complication

United States
Xiaotong Hou

Not yet recruiting

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation

Extracorporeal Membrane Oxygenation Complication

China
Clinica Mediterranea

Completed

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients (NAPLESIII)

Bleeding

Italy
Xijing Hospital

Unknown

Cocktail Injection Improves Outcomes of FFR Guided PCI (CocktailII)

Acute Coronary Syndromes

China
Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
HaEmek Medical Center, Israel

Completed

ACRIPAB- Trial: Anti Coagulation Regimen In High Risk PAtients for Bleeding (ACRIPAB)

Hematologic Diseases

Israel
Children's Hospital Los Angeles
Baylor College of Medicine; Children's Hospital of Philadelphia; Children's Hospital... and other collaborators

Completed

The UNBLOCK Study: Utilization of Bivalirudin On Clots in Kids (UNBLOCK)

Deep Venous Thrombosis

United States
Nycomed

Completed

ImproveR International (BI-001-IM)

Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)

Denmark
Boston Children's Hospital

Recruiting

Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation

Drug Effect

United States
Beijing Anzhen Hospital
Chinese Academy of Medical Sciences, Fuwai Hospital; ACTION Study Group (Pitié-Salpêtrière...

Completed

Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI (RIGHT)

STEMI - ST Elevation Myocardial Infarction

China
Istituto Clinico Sant'Ambrogio
Istituto Clinico Humanitas; Azienda Ospedaliera Niguarda Cà Granda; Centro Cardiologico...

Unknown

Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI

ST-Elevation Myocardial Infarction | Primary Percutaneous Coronary Intervention

Italy
Qian Gong

Unknown

Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)

Coronary Heart Disease
Han Yaling, MD

Completed

Reduce Bolus Injection of Bivalirudin

Acute Coronary Syndrome

China
HLB Pharmaceutical Co., Ltd.

Unknown

Phase 1 Single Dose Escalation Study of CTB-001

Healthy

Korea, Republic of
NYU Langone Health
Guerbet

Completed

Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography

Coronary Artery Disease

United States
Regado Biosciences, Inc.
Icahn School of Medicine at Mount Sinai; The Cleveland Clinic; Parexel; Duke Clinical... and other collaborators

Terminated

A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI (Regulate)

Coronary Artery Disease

United States
University of Roma La Sapienza

Unknown

Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial (BILLION)

Coronary Artery Disease

Italy
Stony Brook University

Terminated

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

Coronary Artery Disease

United States
Laval University

Unknown

EArly Discharge After Transradial Stenting of CoronarY Arteries in High-Risk Patients of Bleeding (EASY-B2B)

Coronary Artery Disease

Canada
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

STEMI With Multivessel Coronary Disease

China
The First Affiliated Hospital of Dalian Medical...
Beijing Friendship Hospital

Unknown

Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention.

Aging | Acute Coronary Syndrome | Percutaneous Coronary Intervention | Anticoagulants and Bleeding Disorders

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

Bivalirudin in Acute Myocardial Infarction

Acute Myocardial Infarction

China
Shanghai Zhongshan Hospital

Unknown

Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion

Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk

China
The Medicines Company

Completed

Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)

Cardiovascular Disease | Coronary Artery Bypass Surgery

United States
Haaglanden Medical Centre
Takeda; Leiden University Medical Center

Not yet recruiting

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH) (CIAO@SAH)

Subarachnoid Hemorrhage, Aneurysmal
The First Affiliated Hospital of Dalian Medical...
Beijing Friendship Hospital

Unknown

Bivalirudin in Elderly Patients With Acute ST-segment Elevation Myocardial Infarction (BEST)

Percutaneous Coronary Intervention | Aged | STEMI

China
Sydney Local Health District

Not yet recruiting

BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation (BLUSH)

Extracorporeal Membrane Oxygenation Complication

Australia
University of Texas Southwestern Medical Center

Completed

Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO

Pediatric ALL | Extracorporeal Membrane Oxygenation Complication | Anticoagulants

United States
The Medicines Company

Terminated

Bivalirudin Infusion for Ventricular Infarction Limitation (BIVAL)

Acute Myocardial Infarction

Netherlands, France

Search clinical trials for: Bivalirudin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations